Category: Health Fitness

Mumbai: Dr Reddy’s Laboratories has entered into a collaboration with Reykjavik, Iceland-based biotech company Alvotech to co-develop, manufacture and commercialise a biosimilar version of blockbuster...

New Delhi: Prices of active pharmaceutical ingredients (API) used for manufacturing drugs are seeing a significant drop, bringing relief to India's pharmaceutical industry. The pharma...

Dr Reddy's Laboratories on Thursday said it has joined hands with global biotech firm Alvotech to co-develop and commercialise a biosimilar product for treating multiple...

With Covid-19 cases surging significantly, the Union ministry of health has advised people to avoid crowded places when unwell and practice hand hygiene.A series of...

The revered city of Ujjain, nestled in the heart of Madhya Pradesh, is poised to become the epicentre of a transformative dialogue on June 5...

Zydus Lifesciences plans to acquire US-based Agenus Inc’s biologics manufacturing facilities in California, a deal which will mark the Indian pharma company’s entry into the...

New Delhi: Medical representatives will no longer be allowed to meet doctors directly in central government hospitals, as the Centre has ordered banning their entry...

Mumbai: Morbid as it may sound, rising heart ailments have expanded the market for cardiovascular drugs in the country.Drugs across the cardiac category, including medications...

French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical company specializing in systemic mastocytosis, a rare immunological disease, the companies...

New Delhi: Niti Aayog will soon come up with a blueprint on improving quality of brain health and recognising early signs of cognitive disorders and...

Sun Pharmaceutical Industries has lined up a USD 100 million investment to commercialise innovative products in the current fiscal, according to Chairman and Managing Director...

A high-stakes legal battle has erupted ahead of the anticipated launch of Novo Nordisk’s blockbuster weightloss drug Wegovy (semaglutide) in India. The Delhi High Court...

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first...

Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for its generic version of amlodipine and atorvastatin tablets, used...

IHH Healthcare's Singapore-headquartered indirect subsidiary Northern TK Venture Pte Ltd (NTK) on Thursday said Daiichi Sankyo's "misleading statements" concerning the Fortis Healthcare open offer continue...

Singapore-based Northern TK Venture (NTK), an indirect subsidiary of Malaysia's IHH Healthcare, on Thursday said Japanese drug maker Daiichi Sankyo's latest release contained "misleading statements"...

Laghu Udyog Bharati (LUB), an association of small businesses which is an affiliate of the Rashtriya Swayamsevak Sangh (RSS), has urged the government to waive...

The drug regulatory authority said unused and expired opioid drugs and painkillers at homes should be mandatorily discarded to prevent any misuse and adverse health...

Drug maker Lupin on Monday said it has entered into a licence and supply agreement with SteinCares for commercialisation of biosimilar ranibizumab across Latin America,...

India will soon come up with a structured framework for critical care to address the infrastructure and human resource gap in the sector, officials said.The...

In a first-of-its-kind pricing strategy in the pharmaceutical industry, Swiss drug major Novartis has introduced a financing scheme for its cholesterol lowering drug brand Sybrava...

Mumbai: Quadria Capital, an Asia healthcare-focused private equity firm, has raised $1.07 billion for its third fund, exceeding its original target of $800 million, according...

BENGALURU/MUMBAI: A decade ago, India’s health supplements mostly meant vitamin C, iron and B12 tablets purchased at pharmacies after consulting a doctor.Fast forward to 2025,...

Dr Reddy's Laboratories has received Form 483 with two observations after the US health regulator inspected its API manufacturing plant in Telangana. The US Food...

In view of the recent increase in Covid-19 cases, the Delhi government Friday issued an advisory, asking hospitals to prepare in terms of availability of...

When the world sneezes from a US-China chill, Indian companies rush to make medicines. Literally. Sometime in April, Vivek Sharma, executive chairman of Suven Pharmaceuticals,...

Pharma major Venus Remedies on Saturday said it has successfully renewed its good manufacturing practices (GMP) certification from Ukraine's State Service on Medicines and Drugs...

Sun Pharmaceutical Industries Ltd on Friday said it has entered into an agreement with US-based Pharmazz Inc to invest up to USD 25 million, resulting...

Zydus Lifesciences is working on a differentiated single device that can be calibrated for use of semaglutide in multiple strengths, a senior industry executive told...

Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III clinical trials. The vaccine maker, in a press...

Neuberg Diagnostics, a leading diagnostic service provider, formed a joint venture with Maharashtra-based Star Imaging, a leader in advanced medical imaging, to expand integrated diagnostic...

New Delhi: Many pharmaceutical companies in the micro, small and medium enterprise (MSME) sector are manufacturing substandard drugs, according to the data by India's drug...

Malaysia's IHH Healthcare has increased its damages claim by a tenfold to approximately Rs 11,800 crore from Japan's Daiichi Sankyo for blocking its bid for...

Aman Mehta, third generation of Torrent Group's founder Mehta family, was on Tuesday appointed Managing Director of the conglomerate's flagship Torrent Pharmaceuticals. He is son...

Leading Indian drugmakers such as Eris Lifesciences, Lupin, Mankind and Wockhardt are making strong inroads into the country's insulin market-long dominated by multinationals such as...

India's orthopaedic and cardiac implant sector is expected to reach USD 4.5-5 billion by 2027-28, mainly driven by strong domestic demand and gradually growing exports,...

Piramal Pharma has no plans to enter domestic prescription formulations business for now, chairperson Nandini Piramal told ET, putting to rest speculations that the company...

The U.S. Food and Drug Administration said on Friday it had cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, making the test the first...

Dr Reddy's Laboratories on Saturday said the US health regulator has issued a Form 483 with two observations after inspecting its US-based facility. The US...

As a professional from the pharmaceutical industry, Diogo Rau, the global chief information and technology officer at Eli Lilly, is surprisingly candid. Rau has worked...

New Delhi: Personal care products containing aloe vera, jojoba oil and orange oil may be harmful and are likely to be banned soon after the...

Mumbai: India's biotech flagship Biocon's profitability is being pulled down by structured venture debt prompting it to look at a fundraise of '4,500 crore to...

Generic drug companies in India are not expected to be affected by US President Donald Trump's new order to bring the prices for prescription (Rx)...

New Delhi: Vaccines, antimicrobials, narcotic drugs and psychotropic substances, and additional cancer drugs would have to mandatorily print or affix bar codes or quick response...

New Delhi: RSS affiliate Laghu Udyog Bharati (LUB), which supports the small-scale industry, has urged the government to drop the requirement of compulsory testing of...

Dr Stuti Khare Shukla, MD Dermatologist, fondly called as Hair Growth Queen of India & Celebrity Hair Specialist of Bollywood Hair loss is now a...

Mumbai: US President Donald Trump’s executive order to drugmakers to lower medicine prices in the US to levels other countries pay could benefit generics companies,...

The US government's order to pharma firms to lower the cost of prescription medicines within 30 days will not impact Indian generic drugmakers, Cipla MD...

Mumbai: President Donald Trump’s sweeping plan to reduce prescription drug prices in the United States may impact Indian pharmaceutical companies, many of which earn a...

India has not accepted the demand of the UK for inclusion of a 'data exclusivity' provision in the free trade agreement, announced on May 6,...

India's pharma industry is likely to see a sharp increase in the number of surprise inspections by the US Food and Drug Administration (FDA) after...

In less than two months after diabetes drug Empagliflozin went off patent, Indian branded generic players have crowded the market with their versions of the...

Pharma major Dr Reddy’s Laboratories Ltd is increasingly focussing on launching innovative products through partnerships with an aim to grow at 15-16% in India, a...

Biopharmaceutical firm Biocon plans to invest $150 million in capital expenditure over the next couple of years, with $100 million earmarked for its biologics division...

Zydus Lifesciences on Friday said it has received approval from the US health regulator to market a generic medication to treat multiple sclerosis. The company...

Drug firm FDC Ltd is recalling over 60,000 bottles of a generic medication, used to treat glaucoma, in the US market due to manufacturing issue,...

Only a small number of pharmaceutical companies have submitted plans for upgradation of facilities even as a revised deadline for implementation of revised Schedule M...

The recent executive orders on pharma issued by President Donald Trump are expected to create significant challenges for Indian pharmaceutical companies, especially those operating in...

Consumption of Mounjaro, Eli Lilly's blockbuster weight-loss drug, more than tripled within a month of its launch in India, according to data from industry tracker...

Aster DM Healthcare on Wednesday said it will invest Rs 480 crore to set up a 430-bed multispecialty hospital in Bengaluru. The company has signed...

New Delhi: A day after ET broke the news that the government is giving final touches to a set of guidelines for biosimilar drugs, India's...

TPG has agreed to acquire a 35% stake in drug containment firm SCHOTT Poonawalla from Serum Institute of India (SII). The decision was announced on...

The government is giving final touches to a revised set of regulations to set stringent quality standards for research and manufacture of biosimilar drugs, which...

New Delhi: Biocon Ltd on Monday said its arm Biocon Biologics Ltd has secured multiple market access agreements in the US for its biosimlar, Yesintek,...

Manipal Hospitals, Singapore’s IHH Healthcare, Blackstone-owned hospital chain Quality Care India, Max Healthcare, KKR & Co. and EQT Partners are among those that have submitted...

India could receive the dengue vaccine as early as next year. According to a report by the Times of India, Japanese pharmaceutical giant Takeda is...

Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to manufacture the generic version of cholesterol lowering Niacin...

Mumbai: Inroads of blockbuster weight-loss medications such as Eli Lilly’s Mounjaro and Wegovy that Novo Nordisk is expected to bring to India may result in...

New Delhi: The country's top advisory body on drugs has proposed to constitute a sub-committee to decide if people can continue to get medicines at...

Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market a generic medication for the prevention of heart attack...

The government is considering bringing the controversial opioid Tapentadol under the Narcotic Drugs and Psychotropic Substances (NDPS) Act following allegations of unbridled exports of the...

Leading healthcare service providers Aster DM Healthcare has completed acquisition of 5% stake in Quality Care India Ltd (QCIL) from BCP Asia II TopCo IV...

New Delhi: Despite concerns over presence of cancer causing agents in popular antacid Ranitidine and a recent recommendation by an expert panel for suspension of...

Drugmaker BDR Pharmaceuticals is looking to expand its US footprint through buyouts of manufacturing facilities with an investment of $100 million, its Chairman & Managing...

New Delhi: Private hospital chain Max Healthcare plans to invest Rs 6,000 crore over the next three years to expand its network across key locations...

Max Healthcare Institute Ltd will invest Rs 6,000 crore by 2028 to add 3,700 beds across key locations in India, its Chairman and Managing Director...

Dr Reddy's Laboratories on Monday said it has expanded its partnership with Sanofi Healthcare to introduce a novel drug for the prevention of lower respiratory...

Global Health, which operates hospitals under the Medanta brand, on Monday said it plans to invest around Rs 500 crore to set up a 400-bed...

New Delhi: Commerce and industry minister Piyush Goyal Sunday said that India “very often” gets requests to grant fresh patents for a longer period of...

India’s pharma and healthcare sector continue to see rising investor interest with an increasing shift in focus to scalable and global models despite a quarterly...

The Delhi High Court on Thursday directed pharmaceutical companies to issue advisories to doctors, chemists, and retailers stating that fixed-dose combination (FDC) cough syrups must...

Zydus Lifesciences on Saturday said the US health regulator has issued six observations after inspecting its Gujarat-based API manufacturing unit. "We wish to inform that...

New Delhi: To ensure timely access to life saving orphan drugs, the government has exempted mandatory sampling and testing of orphan drugs at port offices....

SS Innovations International - the developers of indigenous surgical robotic technologies - said on Thursday that it has listed on US exchange Nasdaq.Sudhir Srivastava, Chairman...

In a rare acknowledgement of India's strategic importance, Reckitt Benckiser Group Plc's global chief executive officer Kris Licht said the country stands out as a...

In a relief to pharma companies, including Glenmark Pharmaceuticals and Zuventus Healthcare, the Delhi High Court on Thursday held that the government's April 15 notification...

New Delhi: India's top advisory board on drugs is considering a plan to rein in the sale of commonly used over-the-counter (OTC) medications to prevent...

Aurobindo Pharma on Wednesday said its wholly- owned arm Eugia Pharma Specialities Ltd has received final approval from the USFDA to manufacture and market its...

India's premier health research body has recommended a ban on popular painkiller and anti-fever medicine Nimesulide in patients below 18 years and those who are...

Dr Reddy's Laboratories and Lupin are recalling products in the US market due to labelling and manufacturing errors, respectively, according to the US health regulator....

An Indian pharma company is caught in the Russian-Ukraine conflict zone, prompting a pharma lobby group to seek Prime Minister Narendra Modi's intervention.The Federation of...

Former Fortis Healthcare promoter Shivinder Mohan Singh has moved a plea before the National Company Law Tribunal for personal insolvency, stating that his liabilities far...

New Delhi: Pharmacists have raised questions on the procedure to handle several medicines that were recently banned for use in children below four years of...

Nearly 19 years after two Mumbai-based couples made medical history by donating kidneys to each other’s spouses, the central government is now moving to promote...

Mumbai: Uncertainty over US tariffs and global macroeconomic headwinds have slowed down the hiring momentum at pharmaceutical and healthcare global capability centres (GCCs) in India,...

New Delhi: Hectic discussions were held in the Union health ministry this week to weigh options to shield India's pharmaceutical industry from an imminent tariff...

New Delhi | Mumbai: A new oral pill for weight loss has moved a step closer to commercial launch, raising hopes for millions who suffer...

Divi's Laboratories on Friday said it has inked a supply agreement with a global pharmaceuticals firm. Under the long-term agreement, the company will be manufacturing...

New Delhi: The government last week prohibited the use of certain cough syrup brands for those below four years of age, citing safety issues. The...

Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator to market a generic anticonvulsant medication. The company has received approval...

New Delhi: India's drug regulator has ordered companies to stop manufacture and sale of 35 fixed dose combinations (FDCs), saying they compromise "patient safety" and...

The Central Drugs Standard Control Organisation (CDSCO), the apex regulatory authority for pharmaceuticals in India, has mandated that drug regulators across all states and Union...

New Delhi: Amid the sweltering heat, demand for dehydration-preventing drinks has soared in India. According to market research firm PharmaTrac, sales of the widely used...

AstraZeneca Pharma India Ltd on Tuesday said it has surrendered the marketing authorisation of prostate cancer treatment drug Olaparib (Lynparza) 100mg and 150mg in India...

Mumbai: Sanofi India has started the process of selling its flagship insulin brand, Lantus, with major domestic pharmaceutical companies such as Glenmark, Dr. Reddy's Laboratories,...

Hyderabad-based pharmaceutical major Dr Reddy's Laboratories on Monday rejected a media report that claimed that the company is reducing its workforce costs by 25 per...

NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA)...

India's healthcare expenditure will surge from 3.3 per cent to 5 per cent of its GDP by 2030, said CareEdge in its latest report.highlighting the...

Investors who have turned upbeat about India's healthcare assets over the past one year are also examining the sec tor-comprising pharmaceutical companies, hospitals and di-agnostic...

Habib Khorakiwala, Chairman of pharma company Wockhardt on Friday indicated that any imposition of tariffs on pharma products by the US administration would be counterproductive...

Indian drug makers such as Dr Reddy's Laboratories, Zydus Lifesciences and MSN Labs are setting up new manufacturing capacities as they race to launch copies...

Aurobindo Pharma Ltd on Friday said the US health regulator has issued a Form 483 with 11 observations to the Raleigh plant at North Carolina,...

India's booming pharma deal market may hit a rough patch due to the prevailing uncertainty over potential US tariffs on the sector, Stefano Beschi, partner...

Sun Pharmaceutical Industries Ltd on Thursday said a US court has ruled in its favour and vacated a preliminary injunction effective immediately removing restrictions on...

Mumbai: Drugmaker Natco Pharma has said it will price its rare disease drug Risdiplam used to treat spinal muscular atrophy at ₹15,900 per bottle, against...

Drug firms Glenmark and Biocon are recalling products in the US for manufacturing issues, according to the US health regulator. In its latest Enforcement Report,...

President Donald Trump on Tuesday announced that the U.S. will soon introduce a "major" tariff on pharmaceutical imports. Speaking at an event organized by the...

The Union Health Ministry is planning to roll out capacity building activities for frontline workers involved in administration of Human Papillomavirus (HPV) vaccination, sources said....

MUMBAI: Bulge-bracket private equity funds are increasingly investing in single-speciality Indian hospital chains that present a robust growth potential in emerging consuming centres, significantly widening...

Sun Pharmaceutical Industries on Monday said it has introduced a medication for the treatment of Erosive Esophagitis of all grades. The Mumbai-based drug major, in...

Danish pharma giant Novo Nordisk is preparing to launch blockbuster anti-diabetes and weight-loss drug Wegovy (semaglutide) in India. To get an edge over Eli Lilly's...

Health insurance sector in India is facing a paradox. While premium collections have surged dramatically, insurers are grappling with a slowdown in the number of...

In a major blow to the medical devices sector, the US President Donald Trump imposed a steep 27% reciprocal tariff on the med tech industry...

Kerala Health Minister Veena George on Saturday announced that digital payment systems have been introduced in government hospitals across the state to facilitate fee payments...

Mumbai: The relief at being spared from reciprocal tariffs did not last long for India's drug makers, with US President Donald Trump declaring that pharma...

Bengaluru-based People Tree Hospital secures ₹220 crore investment from BlackRock, the world’s largest asset management firm, to expand its capacity to 400 beds and transform...

Large Indian drug makers, some of which get as much as half their revenue from the US market, were relieved as President Donald Trump spared...

The US administration has exempted pharmaceuticals from reciprocal tariffs, underscoring the critical role played by generic medicines globally, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan...

Fortis Healthcare has purchased the Fortis trademark previously owned by the company’s erstwhile promoters, brothers Malvinder and Shivinder Singh, in an auction process for Rs....

Mumbai: Swiss pharma giant Novartis AG's plans to sell a 70.68% equity stake in its listed arm Novartis India has been hobbled as wild swings...

New Delhi: Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, on Tuesday announced a partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) for advancing the...

India’s exporters are bracing for President Donald Trump’s tariffs. Some are confident that whatever is announced on Wednesday will not hurt them; others are genuinely...

India has developed its first indigenous MRI machine, set to be installed at AIIMS Delhi by October for trials. The move aims to reduce treatment...

Healthcare provider Ankura Hospitals on Monday said it has secured Rs 165 crore in funding from the Asian Development Bank (ADB). The strategic investment is...

Mumbai: Global investment firm KKR is in discussions with US fund Comvest Investment Partners, to acquire Leixir Dental Laboratory Group, a US-based dental solutions provider,...

The division bench of the Delhi High Court on Wednesday asked Natco Pharma to maintain status quo on the launch of its drug Risdiplam till...

In today's fast-evolving healthcare landscape, digital skills are no longer optional—they're a key advantage. The demand for healthcare professionals extends beyond traditional roles, creating opportunities...

The Central Drugs Laboratories in its monthly drug alert for February found 47 drug samples manufactured by various firms to be "not of standard quality...

Mumbai: Eli Lilly, the world's most-valued drugmaker that seeks to shake up India's lifestyle disease management through its recent introduction of weight-loss injectable Mounjaro, is...

Kotak Alternate Asset Managers on Wednesday announced a Rs 1,050-crore investment in Tirupati Medicare, which will support the pharma company's expansion efforts. The investment also...

Prices of essential medicines, such as painkillers, antibiotics, anti-infectives, anti-diabetics and cancer drugs, will see a modest increase from April 1. The government has allowed...

New Delhi: Deaths and soaring global HIV infections would be the direct result of US President Donald Trump's decision to "suspend" programmes aided by the...

Homegrown Kedaara Capital and US-based TA Associates are among a clutch of private equity (PE) firms in talks to acquire a significant minority stake in...

Eli Lilly's global CEO David Ricks is spearheading the worldwide launch of popular diabetes and anti-obesity drugs Mounjaro and Zepbound. On a visit to India,...

Mumbai | New Delhi: Pharma major Eli Lilly is open to partnerships with Indian companies to sell its blockbuster anti-diabetes and weight loss drug Mounjaro...

Healthcare product company, Entero Healthcare Solutions, has announced the launch of its "HealthEdge" program to modernise retail pharmacies. Entero also announced the acquisition of Aayu...

The Delhi High Court on Monday rejected Swiss multinational F. Hoffmann-La Roche AG’s petition seeking to temporarily restrain Natco Pharma from infringing its product patent...

Health and Family Welfare Minister JP Nadda said the government is following a comprehensive health policy that includes use of artificial intelligence in detecting tuberculosis...

New Delhi: India is planning to develop left ventricular assist devices (LVADs), which help the heart pump blood, people familiar with the matter told ET....

It is an incredibly challenging time for global funding with the Global North focusing inwards but it's also "a real moment of opportunity for Indian...

Indian vaccine maker Bharat Biotech said on Thursday it had invested $75 million in its first cell and gene therapy (CGT) facility in the southern...

MUMBAI: Bharat Biotech, India's leading vaccine maker, is investing Rs 600 crore to expand into cell and gene therapies, the emerging frontier in treating cancers,...

Mumbai: Diagnostics chain Metropolis Healthcare plans to acquire 2-3 companies every year over the next few years to expand its presence, especially in northern and...

Guess what? There's this shot you can get—Rs 14,000 a month—for weight loss.But, but, but… India’s obesity problem is no small fry, and Big Pharma...

New Delhi: US pharmaceutical major Eli Lilly on Thursday introduced its globally popular anti-diabetes and obesity drug Mounjaro (tirzepatide) in India, kicking off a raft...

Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country's drug regulator, it said on Thursday. A...

New Delhi: The Association of Indian Medical Device Industry (AiMeD) has urged the government to impose safeguard duties on 12 medical device categories to protect...

New Delhi: Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US Food and Drug...

Zydus Lifesciences Ltd on Tuesday said it has received final approval from the US health regulator to manufacture a generic version of Apalutamide tablets used...

New Delhi: The All India Institute of Medical Sciences (AIIMS) is reeling under an acute shortage of staff, with 430 posts of doctors and 2,109...

The government may offer easier market access for US medical device firms as part of its efforts to mitigate the potential impact of the US...

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in India, according to results of...

GV Prasad, co-chairman and managing director, Dr Reddy's Laboratories says large mergers and acquisitions in the Indian pharmaceutical market are unlikely in the near future...

Prolonged use of steroid-based inhalers for respiratory issues like asthma and bronchitis, frequent application of nasal sprays for allergies, and steroid-containing skin creams for allergic...

The world looked on in awe as DeepSeek, a tiny artificial intelligence (AI) star tup in Hangzhou, overnight shook the foundation of Silicon Valley giants....

Thiruvananthapuram, India became a vaccine superpower with Covaxin's development and now produces 60 per cent of the world's vaccines, said Prof Balram Bhargava, former Director...

A parliamentary committee has expressed concern over posts of scientists in the Department of Health Research (DHR) lying vacant for an "unacceptably" long time and...

Dr. Reddy’s Laboratories is recalling Lot No: A1540076 of Levetiracetam 0.75% Sodium Chloride Injection, 1,000 mg/100 mL, single-dose infusion bags in the United States. The...

The Parliamentary Standing Committee on Health and Family Welfare, in its latest report, has expressed concerns over the functioning of India's drug regulatory authority-Central Drugs...

A study linking Indian-made generic drugs to a higher risk of serious side effects in the US has drawn backlash from the industry’s most influential...

Global buyout funds Blackstone, Hillhouse Investment, TPG Capital, and General Atlantic have submitted non-binding bids to acquire AGS Health, valuing the healthcare IT services firm...

Several domestic drug companies today launched the blockbuster diabetes drug Empagliflozin with domestic drugmaker- Mankind pharma launching it at 90 per cent less than the...

The charitable trust that runs Mumbai's well-known Lilavati Hospital on Tuesday alleged that funds to the tune of over Rs 1,500 crore were misappropriated by...

India's Syngene International on Monday said it has acquired its first biologics facility in the United States from Emergent Manufacturing Operations Baltimore, a unit of...

Mumbai-based Aveo Pharmaceuticals said the company has been issued stop-production notice for non-compliance with manufacturing standards and not for export of opioid-based drugs to West...

Zydus Lifesciences on Monday said it has received approval from US health regulator USFDA to market a generic antifungal medication to treat dandruff, fungal infections,...

The Pharmaceuticals Export Promotion Council (Pharmexcil) has sought a review of a new rule for drug exports that requires a product registration certificate from the...

The US health regulator has pulled up Granules India for failing to maintain buildings for drug storage and avoiding adequate procedures regarding cleaning and maintenance...

Hyderabad-based Apollo Health & Lifestyle Limited (AHLL) has acquired a controlling stake in Lucknow-based Care Diagnostics for an undisclosed sum in an all cash deal.A...

The country has witnessed an alarming surge in counterfeit medicines flooding retail markets, a spike of nearly 50 per cent over and above the estimated...

New Delhi: Delhi Health Minister Pankaj Singh announced on Thursday that the registration process for the Ayushman Bharat scheme will begin after March 8, marking...

Did you know that heart disease is a leading cause of around 17.9 million deaths worldwide per year?1 If you have diabetes, your risk for...

Mumbai: The Indian Pharmaceutical Alliance (IPA), which represents the country's largest drug makers such as Cipla, Dr Reddy's Laboratories and Lupin, has suggested to the...

A private eye hospital in the city has announced a breakthrough in LASIK surgery, reducing treatment time to under 10 seconds per eye using an...

All clinical research organisations in India will have to get registered with the country's drug regulatory authority by April 1, in what could bring more...

Gujarat-based Senores Pharmaceuticals on Tuesday said it will acquire a basket of 14 Abbreviated New Drug Applications from Dr Reddy's Laboratories for an undisclosed amount....

India is likely to get a list of drugs which will become over the counter (OTC) from a prescription drug, this month. The sub committee...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with support from the Gates Foundation,...

AstraZeneca Pharma India Ltd on Monday said it has received approval from drug regulator CDSCO to import and distribute cancer treatment medicine Durvalumab solutions in...

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes drug in the next four to five...

Mumbai: A looming threat of reciprocal tariffs on exports of pharmaceuticals from India by US President Donald Trump initially caused worries of a negative impact....

Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the US...

The healthcare and education systems are being plagued by commodification and commercialisation, said Vice President Jagdeep Dhankhar on Saturday, underscoring that philanthropic endeavours should not...

Union Health Minister JP Nadda on Saturday flagged off the Jan Aushadhi Raths to kick off the Jan Aushadhi Saptah being celebrated from March 1...

Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces for U.S. President Donald Trump's plans...

Did you know that obesity isn't just about carrying extra weight? It can have serious effects, especially if you are living with diabetes. When it...

New Delhi: The Department of Pharmaceuticals (DoP) has formed a technical committee to formulate the strategy and a roadmap for an action plan to strengthen...

India's contract drug makers have urged the government to remove regulatory hurdles and grant faster clearance to vital raw material imports at a time when...

Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the...

India's Contract Research Development and Manufacturing Organisation (CRDMO) sector is at an inflection point, with the potential to grow to USD 22-25 billion by 2035,...